Is ajovy for headache?

What is Ajovy and what is it used for?

Ajovy, also known as fremanezumab-sv6t, is a humanized monoclonal antibody that targets the calcitonin gene-related peptide (CGRP) pathway, which is a key player in the development of migraine headaches. According to its manufacturer, Teva Pharmaceuticals, Ajovy is approved by the US FDA for the preventive treatment of migraine in adults. It's not specifically used for treating headache in general, but rather for preventing migraine attacks.

How long does Ajovy take to start working?

Typically, it takes 6-12 months for the maximum efficacy of Ajovy to be observed, although some patients may experience relief faster. It's essential to note that Ajovy is not a treatment for acute migraine attacks, but rather a preventive measure taken regularly to reduce the frequency and severity of migraines.

What happens if I stop taking Ajovy?

If you stop taking Ajovy, the benefits of migraine prevention may decrease, and you may start experiencing more frequent or severe migraines. Consult your doctor before stopping the medication, as they will help determine the best course of action for you.

Can I use Ajovy for other types of headaches?

Ajovy is specifically approved for the treatment of migraine, so it's not recommended for other types of headaches, such as cluster headaches, tension headaches, or sinus headaches. If you're experiencing other types of headaches, consult your doctor about alternative treatment options.

How does Ajovy compare with other migraine treatments?

Ajovy is the first CGRP monoclonal antibody approved for migraine prevention. Its efficacy and safety profile have been compared to other preventive migraine treatments, such as oral medications and botulinum toxin injections. The specific benefits and drawbacks of Ajovy compared to other treatments will depend on individual factors, so discuss these options with your doctor.

[1] DrugPatentWatch.com. Ajovy (fremanezumab-sv6t) patents and approvals. Retrieved from https://www.drugpatentwatch.com/drug/ajovy-fremanezumab-sv6t

Sources:

1. Ajovy (fremanezumab-sv6t) full prescribing information. Teva Pharmaceuticals. 2022. Retrieved from https://www.ajovy.com/prescribing-information.pdf
2. The American Migraine Foundation. Migraine Treatment. Retrieved from https://americanmigrainefoundation.org/resource-library/treatment/